Key Takeaways
- • Raj Rajaratnam, 54-year-old founder of Galleon Group hedge funds, faces sentencing for securities fraud and insider trading convictions, with prosecutors seeking a minimum 19.5-year prison term—potentially the longest sentence in U.S. history for an insider trading case.
- • Federal prosecutors estimate illegal trading profits at $70–$75 million across Rajaratnam's multibillion-dollar fund operations, though defense counsel contests this figure, arguing actual illicit gains were approximately $7 million.
- • The case culminates the largest hedge fund insider trading investigation in U.S. history, initiated with Rajaratnam's October 2008 arrest, resulting in convictions of more than two dozen individuals with sentences ranging from months to 10 years.
- • U.S. District Judge Richard J. Holwell is presiding over the sentencing, with federal guidelines recommending sentences up to 24.5 years; defense arguments include health concerns and claims that a lengthy term would constitute a de facto death sentence for the Sri Lanka native.
- • The prosecution reflects broader enforcement priorities, with then-U.S. Attorney Preet Bharara characterizing insider trading as "rampant and may even be on the rise" in the hedge fund industry following the 2008 financial crisis.
Summary
Raj Rajaratnam, founder of the Galleon Group of hedge funds, faced sentencing in Manhattan on charges of securities fraud and insider trading, with U.S. prosecutors requesting a minimum 19.5-year prison sentence—a term that would constitute the longest sentence ever imposed in a U.S. insider trading case. At 54 years old and once recognized as a billionaire, Rajaratnam's case represents a watershed moment in securities enforcement against the alternative investment industry.
The core dispute centers on the magnitude of illicit profits derived from illegal trading activity. Federal prosecutors calculated illegal gains at $70–$75 million, citing evidence that Rajaratnam's substantial trading volume within his multibillion-dollar fund complex created traceable patterns linking stock price movements to his personal trading decisions. The defense contested this methodology, arguing that when trades executed through his Galleon funds are properly disregarded, actual illegal profits amounted to approximately $7 million—a material difference that would substantially alter sentencing guidelines, which federal prosecutors note extend to 24.5 years.
Rajaratnam's legal team sought leniency based on health considerations, characterizing their client's medical condition as a "unique constellation of ailments" and arguing that a lengthy incarceration would effectively constitute a death sentence. U.S. District Judge Richard J. Holwell held discretion over the final sentence, with the sentencing scheduled for the date of the hearing.
The case emerged from what prosecutors labeled the largest hedge fund insider trading investigation in U.S. history, initiated with Rajaratnam's arrest in October 2008. The probe, led by then-U.S. Attorney Preet Bharara, expanded significantly over subsequent years, ultimately resulting in the conviction of more than two dozen individuals. Sentences across the investigation ranged from several months to 10 years. Bharara subsequently emphasized that insider trading remained "rampant and may even be on the rise" within the hedge fund sector, signaling sustained enforcement commitment.
The core dispute centers on the magnitude of illicit profits derived from illegal trading activity. Federal prosecutors calculated illegal gains at $70–$75 million, citing evidence that Rajaratnam's substantial trading volume within his multibillion-dollar fund complex created traceable patterns linking stock price movements to his personal trading decisions. The defense contested this methodology, arguing that when trades executed through his Galleon funds are properly disregarded, actual illegal profits amounted to approximately $7 million—a material difference that would substantially alter sentencing guidelines, which federal prosecutors note extend to 24.5 years.
Rajaratnam's legal team sought leniency based on health considerations, characterizing their client's medical condition as a "unique constellation of ailments" and arguing that a lengthy incarceration would effectively constitute a death sentence. U.S. District Judge Richard J. Holwell held discretion over the final sentence, with the sentencing scheduled for the date of the hearing.
The case emerged from what prosecutors labeled the largest hedge fund insider trading investigation in U.S. history, initiated with Rajaratnam's arrest in October 2008. The probe, led by then-U.S. Attorney Preet Bharara, expanded significantly over subsequent years, ultimately resulting in the conviction of more than two dozen individuals. Sentences across the investigation ranged from several months to 10 years. Bharara subsequently emphasized that insider trading remained "rampant and may even be on the rise" within the hedge fund sector, signaling sustained enforcement commitment.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.